Cart
sales@molnova.com
CHIR-98014
CAS No. 252935-94-7
CHIR-98014( CHIR98014 | CHIR 98014 )
Catalog No. M13748 CAS No. 252935-94-7
CHIR-98014 is a potent, selective glycogen synthase kinase 3 (GSK-3) withIC50 of 0.65 and 0.58 nM for GSK-3α and GSK-3β, respectively.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 61 | In Stock |
|
| 10MG | 98 | In Stock |
|
| 25MG | 205 | In Stock |
|
| 50MG | 335 | In Stock |
|
| 100MG | 537 | In Stock |
|
| 500MG | 1134 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameCHIR-98014
-
NoteResearch use only, not for human use.
-
Brief DescriptionCHIR-98014 is a potent, selective glycogen synthase kinase 3 (GSK-3) withIC50 of 0.65 and 0.58 nM for GSK-3α and GSK-3β, respectively.
-
DescriptionCHIR-98014 is a potent, selective glycogen synthase kinase 3 (GSK-3) withIC50 of 0.65 and 0.58 nM for GSK-3α and GSK-3β, respectively; shows less potent activities against 20 other protein kinases including Cdc2 and Erk2; causes GS stimulation in CHO-IR cells and rat hepatocytes, with EC50s of 106 nM and 107 nM, respectively; reduces the viability of ES-CCE cells with IC50 of 1.1 uM, results in a significant activation of the Wnt/beta-catenin pathway in ES-D3 cells combined with CHIR-99021; significantly reduces fasting hyperglycemia within and shows improved glucose disposal in diabetic and insulin-resistant db/db mice.
-
In Vitro——
-
In Vivo——
-
SynonymsCHIR98014 | CHIR 98014
-
PathwayPI3K/Akt/mTOR signaling
-
TargetGSK-3
-
RecptorbFGFR|c-Src|GSK-3α|GSK-3β|p70S6K
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number252935-94-7
-
Formula Weight486.3141
-
Molecular FormulaC20H17Cl2N9O2
-
Purity>98% (HPLC)
-
SolubilityDMSO: 11 mg/mL
-
SMILESNC1=C(C=CC(NCCNC2=NC=C(N3C=CN=C3)C(=N2)C2=C(Cl)C=C(Cl)C=C2)=N1)[N+]([O-])=O
-
Chemical Name2,6-Pyridinediamine, N6-[2-[[4-(2,4-dichlorophenyl)-5-(1H-imidazol-1-yl)-2-pyrimidinyl]amino]ethyl]-3-nitro-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Ring DB, et al. Diabetes. 2003 Mar;52(3):588-95.
2. Lian X, et al. Cell Reports. 2015 Jan 13;4(1):170.
molnova catalog
related products
-
5-Bromoindole
5-bromoindole is a potential inhibitor of glycogen synthase kinase 3 (GSK-3)and an important pharmaceutical chemical intermediate.
-
BRD3731
BRD3731 is a potent, selective GSK3β inhibitor with IC50 of 15 nM, 14-fold selectivity for GSK3β over GSK3α (IC50=215 nM).
-
Sulfaphenazole
Sulfaphenazole is an inhibitor of CYP2C9 (Ki: 0.3 μM) that demonstrates at least 100-fold selectivity over other CYP450 isoforms (Ki: 63/29 μM for CYP2C8/CYP2C18, respectively, and no activity at CYP1A1, CYP1A2, CYP3A4, CYP2C19).
